Companies
- Companies
- Browse
Companies
Sankyo Co. Ltd. is currently the second largest pharmaceutical company in Japan. It is famous as the founder of HMG-CoA reductase inhibitor anti-hyperlipidemia drugs. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Mar 2009 - 20 pages - $995
Dec 2010 - 27 pages - $995
Nov 2010 - 40 pages - $500
Feb 2010 - 22 pages - $995
Aug 2010 - 38 pages - $250
Aug 2010 - 37 pages - $250
Mar 2011 - 77 pages - $795
Feb 2010 - 67 pages - $995
Feb 2010 - 65 pages - $995
Sep 2011 - 32 pages - $250
Your selection
Browse By
- Industry sector
- Assay systems
- Diagnostic test systems
- Gene therapy
- Human diagnostics
- Human therapeutics
- Manufacturing
- Nanotechnology
- Other
- Research supplies
- Stem cells
- Therapeutic target
- Age-related disorders (other)
- Back pain
- Birth defects
- Bone cancer
- Chronic granulomatous disease
- Dupuytren's disease
- Dyskinesia
- Fibrocystic breast disease
- Gout
- Growth disorders
- Hypomobility
- Intermittent claudication
- Leprosy
- Lupus erythematosis
- Muscular
- Musculoskeletal disorder (other)
- Scleroderma
- Sjogren's syndrome
- Skeletal
- Trauma, physical
- Wasting disease
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us